Eubank WB - Search Results

1

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).

Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA. Bellon JR, et al. Among authors: eubank wb. Am J Clin Oncol. 2004 Aug;27(4):407-10. doi: 10.1097/01.coc.0000128869.19357.9b. Am J Clin Oncol. 2004. PMID: 15289736

2

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.

Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB. Eubank WB, et al. J Clin Oncol. 2001 Aug 1;19(15):3516-23. doi: 10.1200/JCO.2001.19.15.3516. J Clin Oncol. 2001. PMID: 11481358 Clinical Trial.

3

Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, Lindsley SK, Gralow JR, Austin-Seymour MM, Ellis GK, Livingston RB. Eubank WB, et al. Radiographics. 2002 Jan-Feb;22(1):5-17. doi: 10.1148/radiographics.22.1.g02ja055. Radiographics. 2002. PMID: 11796893 Review.

4

Current and future uses of positron emission tomography in breast cancer imaging.

Eubank WB, Mankoff DA. Eubank WB, et al. Semin Nucl Med. 2004 Jul;34(3):224-40. doi: 10.1053/j.semnuclmed.2004.03.007. Semin Nucl Med. 2004. PMID: 15202103 Review.

5

Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer.

Eubank WB, Mankoff D, Bhattacharya M, Gralow J, Linden H, Ellis G, Lindsley S, Austin-Seymour M, Livingston R. Eubank WB, et al. AJR Am J Roentgenol. 2004 Aug;183(2):479-86. doi: 10.2214/ajr.183.2.1830479. AJR Am J Roentgenol. 2004. PMID: 15269044

6

Evolving role of positron emission tomography in breast cancer imaging.

Eubank WB, Mankoff DA. Eubank WB, et al. Semin Nucl Med. 2005 Apr;35(2):84-99. doi: 10.1053/j.semnuclmed.2004.11.001. Semin Nucl Med. 2005. PMID: 15765372 Review.

7

Current and future use of positron emission tomography (PET) in breast cancer.

Mankoff DA, Eubank WB. Mankoff DA, et al. Among authors: eubank wb. J Mammary Gland Biol Neoplasia. 2006 Apr;11(2):125-36. doi: 10.1007/s10911-006-9019-z. J Mammary Gland Biol Neoplasia. 2006. PMID: 17075687 Review.

8

FDG PET, PET/CT, and breast cancer imaging.

Rosen EL, Eubank WB, Mankoff DA. Rosen EL, et al. Among authors: eubank wb. Radiographics. 2007 Oct;27 Suppl 1:S215-29. doi: 10.1148/rg.27si075517. Radiographics. 2007. PMID: 18180228 Review.

9

Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.

Eubank WB, Mankoff DA, Schmiedl UP, Winter TC 3rd, Fisher ER, Olshen AB, Graham MM, Eary JF. Eubank WB, et al. AJR Am J Roentgenol. 1998 Oct;171(4):1103-10. doi: 10.2214/ajr.171.4.9763005. AJR Am J Roentgenol. 1998. PMID: 9763005

10

[¹⁸F]fluorodeoxyglucose positron emission tomography-computed tomography in breast cancer: when... and when not?

Mankoff DA, Specht JM, Eubank WB, Kessler L. Mankoff DA, et al. Among authors: eubank wb. J Clin Oncol. 2012 Apr 20;30(12):1252-4. doi: 10.1200/JCO.2011.40.6975. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393078 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters